Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections

NCT03176459 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

C-Section
Pain Management

Interventions

DRUG: Exparel + Bupivacaine
DRUG: Bupivacaine

Sponsor

Pacira Pharmaceuticals, Inc